-
Taxonomy & unit
-
ratio: %
-
Description
-
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
-
Summary
-
Hepion Pharmaceuticals, Inc. quarterly/annual Return On Equity history and growth rate from Q2 2015 to Q4 2024.
- Hepion Pharmaceuticals, Inc. Return On Equity for the quarter ending December 31, 2024 was -599 %, a 166% decline year-over-year.
- Hepion Pharmaceuticals, Inc. annual Return On Equity for 2024 was -599 %, a 166% decline from 2023.
- Hepion Pharmaceuticals, Inc. annual Return On Equity for 2023 was -225 %, a 251% decline from 2022.
- Hepion Pharmaceuticals, Inc. annual Return On Equity for 2022 was -64.2 %, a 108% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)